Summary List PlacementInvestors keep pouring cash into biotech, and the surge just helped investment firm Perceptive Advisors raise a new venture fund that's more than double the size of its previous one. Perceptive, which is based in New York, raised $515 million for its second Perceptive Xontogeny Fund, the firm told Insider. Perceptive raised $210 million for its first Xontogeny Fund in 2019. The fund's name references the accelerator Perceptive has a stake in, Xontogeny, led by biotech veteran Chris Garabedian.